Medicare Enrolled
Dr. Armen Cherik, M.D.
Neurology · Glendale, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cherik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cherik?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cherik
Dr. Armen Cherik is a neurology specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cherik performed 7,238 Medicare services across 1,436 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cherik received a total of $25,599 from 83 pharmaceutical and/or device companies across 1297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cherik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in CA
$25,599 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,238
Medicare services
Top 13% in CA for neurology
1,436
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~381 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
5,070 | $4 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
754 | $108 | $250 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
310 | $88 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
299 | $140 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
237 | $66 | $200 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 116 | $221 | $750 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
94 | $188 | $1,000 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
85 | $145 | $450 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
78 | $413 | $800 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
78 | $250 | $700 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
71 | $99 | $250 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
29 | $253 | $1,500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $143 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,599
Total received (2018-2024)
Avg $3,657/year across 7 years
Top 13% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
1,297
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,155 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$444 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,752
2023
$3,651
2022
$4,512
2021
$4,404
2020
$2,081
2019
$3,138
2018
$3,061
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$580
ABBVIE INC.
$568
Alexion Pharmaceuticals, Inc.
$478
Teva Pharmaceuticals USA, Inc.
$251
Neurelis, Inc.
$222
Lundbeck LLC
$222
ACADIA Pharmaceuticals Inc
$174
Lilly USA, LLC
$166
Celgene Corporation
$164
Otsuka America Pharmaceutical, Inc.
$152
Novartis Pharmaceuticals Corporation
$149
SK Life Science, Inc.
$142
Amneal Pharmaceuticals LLC
$137
Eisai Inc.
$128
Vanda Pharmaceuticals Inc.
$109
EMD Serono, Inc.
$97
AstraZeneca Pharmaceuticals LP
$84
Sumitomo Pharma America, Inc.
$79
ARGENX US, INC.
$75
Kyowa Kirin, Inc.
$72
ANI Pharmaceuticals, Inc.
$66
Neurocrine Biosciences, Inc.
$66
Grifols USA, LLC
$62
Genentech USA, Inc.
$61
Merz Pharmaceuticals, LLC
$61
Alnylam Pharmaceuticals Inc.
$55
IDORSIA PHARMACEUTICALS US INC
$54
MDD US Operations, LLC
$49
PFIZER INC.
$45
HARMONY BIOSCIENCES LLC
$37
Boston Scientific Corporation
$35
CSL Behring
$35
BANNER LIFE SCIENCES, LLC
$33
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$18
Top 3 companies account for 34.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,907
Biogen, Inc.
$1,286
Novartis Pharmaceuticals Corporation
$1,159
Alexion Pharmaceuticals, Inc.
$1,138
AbbVie Inc.
$1,112
ABBVIE INC.
$1,081
ACADIA Pharmaceuticals Inc
$949
Teva Pharmaceuticals USA, Inc.
$901
EMD Serono, Inc.
$859
Avanir Pharmaceuticals, Inc.
$854
GENZYME CORPORATION
$771
Kyowa Kirin, Inc.
$744
SK Life Science, Inc.
$723
Amneal Pharmaceuticals LLC
$686
Celgene Corporation
$681
Neurocrine Biosciences, Inc.
$572
Lundbeck LLC
$538
Sunovion Pharmaceuticals Inc.
$493
Neurelis, Inc.
$396
Lilly USA, LLC
$393
Acorda Therapeutics, Inc
$385
Grifols USA, LLC
$362
Genentech USA, Inc.
$360
Supernus Pharmaceuticals, Inc.
$346
Takeda Pharmaceuticals U.S.A., Inc.
$345
Amgen Inc.
$335
Merz Pharmaceuticals, LLC
$311
Adamas Pharmaceuticals, Inc.
$293
AstraZeneca Pharmaceuticals LP
$277
Sumitomo Pharma America, Inc.
$248
PFIZER INC.
$237
Otsuka America Pharmaceutical, Inc.
$228
CSL Behring
$225
Vanda Pharmaceuticals Inc.
$220
Eisai Inc.
$219
Biohaven Pharmaceutical Holding Company Ltd.
$207
Allergan, Inc.
$206
Alnylam Pharmaceuticals Inc.
$205
ARGENX US, INC.
$189
Corium, LLC
$178
Allergan Inc.
$174
IDORSIA PHARMACEUTICALS US INC
$169
Medtronic, Inc.
$167
MITSUBISHI TANABE PHARMA AMERICA, INC.
$148
US WorldMeds, LLC
$148
LivaNova USA, Inc.
$145
Boston Scientific Corporation
$145
Merz North America, Inc.
$136
MDD US Operations, LLC
$120
Biohaven Pharmaceuticals, Inc.
$116
HARMONY BIOSCIENCES LLC
$111
Horizon Therapeutics plc
$100
E.R. Squibb & Sons, L.L.C.
$99
EISAI INC.
$87
BANNER LIFE SCIENCES, LLC
$84
Merck Sharp & Dohme LLC
$74
Harmony Biosciences LLC
$70
Vertical Pharmaceuticals, LLC
$69
Medtronic USA, Inc.
$68
ANI Pharmaceuticals, Inc.
$66
Merck Sharp & Dohme Corporation
$64
Microtransponder, Inc.
$62
Greenwich Biosciences, Inc.
$49
Vertiflex, Inc.
$47
Amarin Pharma Inc.
$46
Esperion Therapeutics, Inc.
$45
Janssen Pharmaceuticals, Inc
$41
Upsher-Smith Laboratories LLC
$26
Mitsubishi Tanabe Pharma America, Inc.
$25
Medtronic Vascular, Inc.
$25
Avion Pharmaceuticals
$24
Abbott Laboratories
$24
Genentech, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$23
ITI, Inc.
$22
Jazz Pharmaceuticals Inc.
$21
Promius Pharma LLC
$19
ARBOR PHARMACEUTICALS, INC.
$19
Octapharma USA, Inc.
$19
Sun Pharmaceutical Industries Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$15
Egalet US Inc
$14
Banner Life Sciences, LLC
$14
Top 3 companies account for 17.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · CAPLYTA · COPAXONE · CREXONT · DUOPA · Dayvigo · Dhivy · EMGALITY · EXSERVAN · EZALLOR SPRINKLE · Endurant · Epidiolex · Fycompa · GENERAL - DBS · GENERAL - PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · HETLIOZ · HYQVIA · Hetlioz · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NEXLETOL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SOLITAIRE X · SPRIX · Soliris · Superion ISS · TECFIDERA · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · Vimpat · WAINUA · WAKIX · Wakix · XADAGO · XCOPRI · XEOMIN · XYREM · Xadago · Xeomin · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
548
Per 100K population
5.6
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cherik is a mixed practice specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cherik experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Cherik performed 5,070 botox injection (xeomin), per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cherik receive payments from pharmaceutical companies?
Yes. Dr. Cherik received a total of $25,599 from 83 companies across 1,297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cherik's costs compare to other neurologists in Glendale?
Dr. Cherik's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cherik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Glendale
Browse neurologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology